Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sharon Pine

Concepts (295)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
30
2023
2199
3.250
 Why?
Carcinoma, Non-Small-Cell Lung
9
2023
973
1.620
 Why?
Amyloid Precursor Protein Secretases
3
2018
73
1.270
 Why?
SOX9 Transcription Factor
3
2023
23
1.230
 Why?
Biomarkers, Tumor
10
2021
1053
1.150
 Why?
Leukemia, Megakaryoblastic, Acute
4
2007
10
0.890
 Why?
Receptor, Notch1
2
2014
61
0.870
 Why?
GATA1 Transcription Factor
4
2007
13
0.850
 Why?
DNA, Neoplasm
4
2010
157
0.790
 Why?
STAT Transcription Factors
1
2021
13
0.790
 Why?
Janus Kinases
1
2021
12
0.790
 Why?
Signal Transduction
9
2021
4521
0.730
 Why?
Paclitaxel
2
2022
190
0.730
 Why?
Inflammation
4
2022
2481
0.660
 Why?
Neoplastic Stem Cells
3
2013
334
0.660
 Why?
Carcinoma, Squamous Cell
3
2022
584
0.650
 Why?
Down Syndrome
4
2007
338
0.630
 Why?
Cell Line, Tumor
13
2023
2725
0.610
 Why?
Benzodiazepinones
1
2017
14
0.590
 Why?
Protease Inhibitors
1
2018
97
0.590
 Why?
Antineoplastic Agents
7
2023
1895
0.580
 Why?
Gene Expression Regulation, Neoplastic
8
2022
1147
0.570
 Why?
F-Box Proteins
1
2016
20
0.540
 Why?
Drug Resistance, Neoplasm
6
2021
642
0.540
 Why?
Antineoplastic Agents, Phytogenic
1
2017
181
0.530
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2005
258
0.530
 Why?
Proteasome Endopeptidase Complex
1
2016
134
0.520
 Why?
Polymerase Chain Reaction
5
2010
994
0.500
 Why?
Ubiquitin-Protein Ligases
1
2016
139
0.500
 Why?
Interleukin-8
3
2014
237
0.490
 Why?
Neoplasms
2
2021
2105
0.470
 Why?
DNA Damage
1
2016
357
0.460
 Why?
Neoplasms, Basal Cell
1
2013
3
0.460
 Why?
Chromosome Segregation
1
2013
36
0.440
 Why?
Cell Cycle Proteins
1
2016
552
0.410
 Why?
Interleukin-6
3
2019
675
0.410
 Why?
DNA
2
2022
1351
0.410
 Why?
Adenocarcinoma
3
2017
801
0.400
 Why?
C-Reactive Protein
2
2011
362
0.400
 Why?
Mannose-Binding Lectin
2
2009
21
0.380
 Why?
Humans
48
2023
114756
0.370
 Why?
Proto-Oncogene Proteins c-mdm2
2
2012
56
0.360
 Why?
Oncogene Proteins, Fusion
3
2017
179
0.360
 Why?
Mutation
9
2023
3350
0.360
 Why?
Mice
12
2023
14916
0.350
 Why?
Cell Transformation, Neoplastic
2
2021
312
0.350
 Why?
Case-Control Studies
13
2020
3005
0.330
 Why?
Polymorphism, Single Nucleotide
6
2019
1892
0.330
 Why?
Smoking
5
2022
1384
0.330
 Why?
Cytokines
1
2015
1843
0.300
 Why?
Polymorphism, Genetic
2
2009
612
0.300
 Why?
Animals
14
2023
31761
0.300
 Why?
Proto-Oncogene Proteins p21(ras)
3
2023
229
0.290
 Why?
Molecular Targeted Therapy
2
2021
347
0.290
 Why?
Inflammation Mediators
2
2021
476
0.290
 Why?
Lymphoma, AIDS-Related
1
2007
13
0.290
 Why?
Leukemia
2
2007
210
0.280
 Why?
Lymphoproliferative Disorders
1
2007
46
0.280
 Why?
Lymphoma, Non-Hodgkin
1
2007
71
0.270
 Why?
Cell Proliferation
7
2021
2196
0.260
 Why?
Breast Neoplasms
2
2013
1868
0.250
 Why?
Female
29
2022
59507
0.240
 Why?
Tumor Microenvironment
3
2023
433
0.240
 Why?
Aged
18
2022
19094
0.230
 Why?
Carboplatin
2
2022
135
0.230
 Why?
Central Nervous System Neoplasms
1
2005
126
0.220
 Why?
Genes, ras
1
2023
91
0.210
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
386
0.200
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
77
0.200
 Why?
Cell Movement
3
2020
867
0.200
 Why?
Epithelial-Mesenchymal Transition
2
2014
168
0.200
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2022
96
0.200
 Why?
Pyrazines
1
2022
71
0.200
 Why?
Base Sequence
4
2014
2118
0.200
 Why?
Immunity, Innate
1
2007
723
0.200
 Why?
Middle Aged
17
2020
26757
0.200
 Why?
Ribosome Subunits, Large, Eukaryotic
1
2021
2
0.190
 Why?
Superoxide Dismutase-1
1
2021
8
0.190
 Why?
Organelle Biogenesis
1
2021
15
0.190
 Why?
Triazoles
1
2022
130
0.190
 Why?
Cytokinesis
1
2021
46
0.180
 Why?
Adenocarcinoma, Mucinous
1
2021
60
0.180
 Why?
Male
23
2022
55579
0.180
 Why?
Phosphatidylinositol 3-Kinases
1
2022
330
0.180
 Why?
Cellular Senescence
2
2013
152
0.180
 Why?
Biomarkers
2
2021
3416
0.180
 Why?
Proto-Oncogene Proteins c-akt
1
2022
399
0.180
 Why?
Receptors, Kisspeptin-1
1
2020
2
0.180
 Why?
Molecular Chaperones
1
2021
157
0.180
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2019
9
0.170
 Why?
Molecular Sequence Data
3
2014
2791
0.170
 Why?
Disease Susceptibility
1
2021
316
0.170
 Why?
Janus Kinase 2
1
2019
31
0.170
 Why?
TOR Serine-Threonine Kinases
1
2022
359
0.170
 Why?
Mice, Inbred NOD
2
2020
561
0.170
 Why?
Risk Factors
8
2015
8627
0.160
 Why?
Cellular Reprogramming
1
2020
84
0.160
 Why?
Acrylamides
1
2019
41
0.160
 Why?
Aniline Compounds
1
2019
70
0.160
 Why?
Neoplasm, Residual
3
2005
104
0.160
 Why?
Combined Modality Therapy
1
2021
1122
0.160
 Why?
Proteolysis
2
2016
143
0.160
 Why?
Nanotechnology
1
2019
113
0.160
 Why?
Lung
4
2022
3546
0.160
 Why?
Carcinogenesis
1
2020
180
0.150
 Why?
Prognosis
6
2021
3334
0.150
 Why?
Quinolines
1
2019
129
0.150
 Why?
Cancer Survivors
1
2022
206
0.150
 Why?
Tumor Suppressor Protein p53
2
2013
447
0.150
 Why?
Disease Management
1
2021
560
0.150
 Why?
Receptors, Notch
1
2018
85
0.150
 Why?
Transfection
2
2017
870
0.150
 Why?
Quinazolines
1
2019
243
0.150
 Why?
Triple Negative Breast Neoplasms
1
2020
158
0.150
 Why?
CD24 Antigen
2
2013
20
0.140
 Why?
Neoplasm Invasiveness
2
2020
445
0.140
 Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
6
0.140
 Why?
Glycogen Synthase Kinase 3 beta
1
2016
60
0.140
 Why?
Hyaluronan Receptors
2
2013
91
0.140
 Why?
Proportional Hazards Models
2
2011
1080
0.130
 Why?
Ubiquitination
1
2016
86
0.130
 Why?
Coculture Techniques
2
2013
201
0.130
 Why?
Protein Interaction Domains and Motifs
1
2016
132
0.130
 Why?
Computational Biology
1
2019
530
0.130
 Why?
Software
1
2019
536
0.130
 Why?
Proto-Oncogene Proteins B-raf
1
2017
193
0.120
 Why?
Protein Kinase Inhibitors
2
2019
795
0.120
 Why?
Cell Division
3
2013
759
0.120
 Why?
Receptors, Interleukin-8B
1
2014
23
0.120
 Why?
Protein Isoforms
2
2013
339
0.120
 Why?
Disease Progression
1
2021
2387
0.120
 Why?
Cell Death
1
2016
322
0.120
 Why?
Energy Metabolism
1
2020
729
0.120
 Why?
Colorectal Neoplasms
1
2021
621
0.120
 Why?
Patient Selection
1
2018
641
0.120
 Why?
Tumor Cells, Cultured
2
2021
854
0.120
 Why?
3' Untranslated Regions
1
2014
129
0.120
 Why?
Ultraviolet Rays
1
2016
366
0.110
 Why?
Research Design
2
2011
931
0.110
 Why?
Platinum Compounds
1
2013
9
0.110
 Why?
Genes, T-Cell Receptor
2
2003
6
0.110
 Why?
Models, Biological
2
2019
1630
0.110
 Why?
Dipeptides
1
2013
48
0.110
 Why?
Lymphocytes, Tumor-Infiltrating
1
2013
114
0.110
 Why?
Core Binding Factor Alpha 2 Subunit
2
2003
31
0.110
 Why?
Alleles
3
2014
791
0.110
 Why?
HIV Infections
1
2007
2469
0.110
 Why?
Immunoglobulin Heavy Chains
2
2003
72
0.100
 Why?
Gene Expression Regulation
1
2021
2321
0.100
 Why?
Survival Analysis
2
2013
1218
0.100
 Why?
Stromal Cells
1
2012
96
0.100
 Why?
Adult
8
2020
30548
0.100
 Why?
Phosphorylation
1
2016
1571
0.100
 Why?
Gap Junctions
1
2012
58
0.100
 Why?
Genotype
4
2014
1774
0.100
 Why?
Risk Assessment
3
2011
2973
0.100
 Why?
Bone Marrow Cells
1
2012
267
0.100
 Why?
National Cancer Institute (U.S.)
1
2011
40
0.100
 Why?
Cell Communication
1
2012
279
0.090
 Why?
Protein Binding
1
2016
1896
0.090
 Why?
Melanoma
1
2017
629
0.090
 Why?
Phenotype
3
2013
2812
0.090
 Why?
AC133 Antigen
1
2010
19
0.090
 Why?
Bromodeoxyuridine
1
2010
72
0.090
 Why?
Infant
3
2007
7935
0.080
 Why?
Biopsy
2
2017
1040
0.080
 Why?
Logistic Models
2
2011
1843
0.080
 Why?
CD8-Positive T-Lymphocytes
1
2013
689
0.080
 Why?
Exons
2
2008
303
0.080
 Why?
Cell Differentiation
2
2008
1699
0.080
 Why?
DNA Replication
1
2010
205
0.080
 Why?
Genetic Predisposition to Disease
4
2012
2099
0.080
 Why?
Prospective Studies
2
2011
6217
0.080
 Why?
Glycoproteins
1
2010
304
0.080
 Why?
Baltimore
1
2007
43
0.070
 Why?
Polymorphism, Single-Stranded Conformational
1
2007
25
0.070
 Why?
Infant, Newborn
3
2007
5035
0.070
 Why?
Antigens, CD
1
2010
443
0.070
 Why?
Smoking Cessation
1
2011
374
0.070
 Why?
Sequence Homology, Nucleic Acid
1
2007
152
0.070
 Why?
Linkage Disequilibrium
1
2007
245
0.070
 Why?
Tobacco Smoke Pollution
1
2009
217
0.070
 Why?
Autophagy
2
2023
233
0.070
 Why?
Neoplasm Staging
3
2017
1176
0.070
 Why?
United States
3
2020
12176
0.070
 Why?
Superoxide Dismutase
1
2008
305
0.070
 Why?
Predictive Value of Tests
1
2011
1796
0.070
 Why?
DNA Primers
2
2008
514
0.070
 Why?
ErbB Receptors
2
2019
560
0.070
 Why?
In Situ Hybridization, Fluorescence
1
2007
313
0.060
 Why?
Disease-Free Survival
1
2007
623
0.060
 Why?
Haplotypes
1
2007
453
0.060
 Why?
Chromosomes, Human, Pair 21
1
2005
31
0.060
 Why?
Gene Knockdown Techniques
2
2021
299
0.060
 Why?
Preservation, Biological
1
2005
7
0.060
 Why?
Remission Induction
1
2005
233
0.060
 Why?
Mice, Knockout
2
2021
2582
0.060
 Why?
MicroRNAs
3
2019
601
0.060
 Why?
Peptides
1
2010
848
0.060
 Why?
Cloning, Molecular
1
2005
524
0.060
 Why?
Reproducibility of Results
2
2019
2763
0.060
 Why?
Chronology as Topic
1
2003
2
0.050
 Why?
Chromosome Breakage
1
2003
21
0.050
 Why?
Gene Expression
1
2008
1420
0.050
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
113
0.050
 Why?
Clone Cells
1
2003
248
0.050
 Why?
Mucins
1
2022
61
0.050
 Why?
Child
4
2009
18352
0.050
 Why?
Immunophenotyping
1
2003
275
0.050
 Why?
Promoter Regions, Genetic
1
2006
1133
0.050
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2003
64
0.050
 Why?
Apoptosis
2
2021
2369
0.050
 Why?
Cell Nucleolus
1
2021
17
0.050
 Why?
Time Factors
1
2011
6124
0.050
 Why?
Gene Expression Profiling
2
2019
1521
0.050
 Why?
Child, Preschool
2
2005
9079
0.050
 Why?
Adenosine
1
2022
202
0.050
 Why?
RNA Processing, Post-Transcriptional
1
2021
82
0.040
 Why?
Fibrosis
1
2022
453
0.040
 Why?
Aftercare
1
2022
186
0.040
 Why?
Mutagenesis, Site-Directed
1
2021
345
0.040
 Why?
Down-Regulation
1
2022
596
0.040
 Why?
Glutaminase
1
2020
10
0.040
 Why?
Recurrence
1
2003
936
0.040
 Why?
RNA Precursors
1
2021
136
0.040
 Why?
Mice, Nude
1
2021
635
0.040
 Why?
Africa, Western
1
2019
16
0.040
 Why?
A549 Cells
1
2019
51
0.040
 Why?
Tumor Stem Cell Assay
1
2019
33
0.040
 Why?
Glutamine
1
2020
91
0.040
 Why?
Exome
1
2020
200
0.040
 Why?
Killer Cells, Natural
1
2022
382
0.040
 Why?
Incidence
2
2019
2312
0.040
 Why?
Nucleotides
1
2020
112
0.040
 Why?
Mice, SCID
1
2020
320
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
706
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2020
115
0.040
 Why?
Tumor Burden
1
2020
261
0.040
 Why?
Survivors
1
2022
411
0.040
 Why?
DNA Mutational Analysis
1
2019
372
0.040
 Why?
Young Adult
3
2020
10463
0.040
 Why?
Immunotherapy
1
2022
475
0.040
 Why?
STAT3 Transcription Factor
1
2019
173
0.040
 Why?
Cell Nucleus
1
2021
554
0.040
 Why?
ROC Curve
1
2019
445
0.040
 Why?
DNA-Binding Proteins
1
2005
1314
0.040
 Why?
Genetic Therapy
1
2019
257
0.040
 Why?
B-Lymphocytes
1
2003
769
0.040
 Why?
Health Status Disparities
1
2019
201
0.040
 Why?
Transcription Factors
1
2005
1528
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2017
63
0.030
 Why?
Risk
1
2019
815
0.030
 Why?
Follow-Up Studies
2
2019
4420
0.030
 Why?
MAP Kinase Signaling System
1
2017
276
0.030
 Why?
Neoplasm Metastasis
1
2017
528
0.030
 Why?
Survival Rate
1
2019
1642
0.030
 Why?
Japan
1
2014
87
0.030
 Why?
Leupeptins
1
2013
9
0.030
 Why?
Cell Survival
1
2017
1021
0.030
 Why?
Macrolides
1
2013
56
0.030
 Why?
Transduction, Genetic
1
2013
113
0.030
 Why?
Octamer Transcription Factor-3
1
2012
16
0.030
 Why?
Ligands
1
2014
564
0.030
 Why?
Mice, Inbred C57BL
1
2021
4710
0.020
 Why?
Cross-Sectional Studies
1
2022
4409
0.020
 Why?
Disease Models, Animal
1
2021
3542
0.020
 Why?
Binding Sites
1
2014
1176
0.020
 Why?
Cohort Studies
2
2012
4901
0.020
 Why?
Early Detection of Cancer
1
2014
328
0.020
 Why?
Neoplasm Proteins
1
2013
385
0.020
 Why?
Recombinant Proteins
1
2013
1233
0.020
 Why?
Genetic Variation
1
2014
876
0.020
 Why?
Adolescent
2
2009
17808
0.020
 Why?
Small Cell Lung Carcinoma
1
2010
82
0.020
 Why?
Confidence Intervals
1
2010
309
0.020
 Why?
Neoplasm Recurrence, Local
1
2014
863
0.020
 Why?
Age Distribution
1
2010
339
0.020
 Why?
Sex Distribution
1
2010
335
0.020
 Why?
Reference Values
1
2010
742
0.020
 Why?
Enzyme Stability
1
2008
62
0.020
 Why?
Aged, 80 and over
1
2019
6350
0.020
 Why?
Homozygote
1
2008
187
0.020
 Why?
Linear Models
1
2010
770
0.020
 Why?
Odds Ratio
1
2010
954
0.020
 Why?
Amino Acid Substitution
1
2008
262
0.020
 Why?
Colonic Neoplasms
1
2009
221
0.020
 Why?
Environmental Exposure
1
2009
374
0.020
 Why?
Cells, Cultured
1
2013
3890
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
928
0.020
 Why?
Comorbidity
1
2010
1449
0.020
 Why?
Erythroid-Specific DNA-Binding Factors
1
2005
18
0.020
 Why?
Genome-Wide Association Study
1
2010
1197
0.010
 Why?
Aneuploidy
1
2005
85
0.010
 Why?
Retrospective Studies
1
2014
12515
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1361
0.010
 Why?
Pine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (295) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)